以质量求发展，以服务铸品牌

护理学报 ›› 2025, Vol. 32 ›› Issue (4): 59-63.doi: 10.16460/j.issn1008-9969.2025.04.059

• 临床护理※外科护理 • 上一篇    下一篇

腹腔热灌注化疗患者术中实施不同目标体温管理的效果观察

刘璐, 朱钰, 曹义, 张华, 彭玉娜   

  1. 天津市第一中心医院 手术中心,天津 300192
  • 收稿日期:2024-08-22 出版日期:2025-02-25 发布日期:2025-03-06
  • 通讯作者: 彭玉娜（1977-）,女,天津人,本科学历,主任护师,护士长。E-mail：yzxpengyn@163.com
  • 作者简介:刘璐（1989-）,女,天津人,本科学历,主管护师。
  • 基金资助:
    天津市医学重点学科（专科）建设项目（TJYXZDXK-045A）

Effect of target temperature management strategy on intraoperative temperature management in patients undergoing hyperthermic intraperitoneal chemotherapy

LIU Lu, ZHU Yu, CAO Yi, ZHANG Hua, PENG Yu-na   

  1. Operation Center, Tianjin First Central Hospital, Tianjin 300192, China
  • Received:2024-08-22 Online:2025-02-25 Published:2025-03-06

PDF (PC)

9

赞

摘要： 目的 观察基于不同目标温度的体温管理策略在腹腔热灌注化疗患者术中体温管理中的应用效果。方法 选取2022年1月—2023年12月在天津市某三级甲等综合医院手术中心接受腹腔热灌注化疗的120例结直肠恶性肿瘤患者,按照时间顺序随机分为对照组和观察组各60例。对照组患者采用传统体温管理方案,观察组患者采用基于不同目标温度的体温管理方案。观察2组患者在腹腔热灌注化疗开始前（T1）、灌注15 min（T2）、灌注30 min（T3）、灌注45 min（T4）和结束灌注即刻（T5）膀胱温和食道温的变化情况,比较2组患者中-重度高热、血压降低、代谢性酸中毒、心律失常和术后寒战等围手术期并发症的发生率,并于治疗后3个月回访患者,观察术后生存和肿瘤复发情况的差异。结果 热灌注开始后,在T3~T5时,观察组患者的食道温较对照组均显著降低,差异有统计学意义（P<0.05）。与对照组相比,观察组患者中-重度高热、血压降低、代谢性酸中毒、心律失常和术后寒战的发生率均显著降低,差异有统计学意义（P<0.05）。结论 腹腔热灌注化疗患者术中接受基于不同目标温度的体温管理可有效预防核心温度过度升高,降低围手术期高热和相关并发症的发生率。

关键词: 结直肠肿瘤, 腹膜转移, 腹腔热灌注化疗, 体温管理, 围手术期护理

Abstract: Objective To observe the effect of temperature management strategy based on different target temperatures on intraoperative temperature management in patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC). Methods A total of 120 patients with colorectal cancer who underwent HIPEC in the operation center of a tertiary grade-A general hospital in Tianjin from January 2022 to December 2023 were selected and randomly divided into control group (n=60) and observation group (n=60) according to chronological order. Patients in the control group were treated with traditional temperature management, ad those in the observation group with temperature management strategy based on different target temperatures. Bladder and esophageal temperatures before HIPEC (T1), 15 min after the beginning (T2), 30 min after the beginning(T3), 45 min after the beginning (T4) and at the end of HIPEC (T5) were observed in the two groups, and the incidence of perioperative adverse events such as moderate to severe hyperthermia, reduction of blood pressure, metabolic acidosis, arrhythmia and postoperative shivering was compared between the two groups. The patients were followed up 3 months after the treatment to observe the differences in postoperative survival and tumor recurrence. Results During HIPEC, esophageal temperature in the observation group was significantly lower than that in the control group at T3-T5, showing statistical significance(P<0.05). Compared with that in the control group, the incidence of moderate to severe hyperthermia, reduction of blood pressure, metabolic acidosis, arrhythmia and postoperative shivering in observation group was significantly lower (P<0.05), showing statistical significance. Conclusion Intraoperative temperature management strategy based on different target temperatures in patients undergoing HIPEC can effectively prevent excessive increase of core temperature and reduce the incidence of perioperative high fever and related complications.

Key words: colorectal neoplasms, peritoneal metastasis, hyperthermic intraperitoneal chemotherapy, body temperature, perioperative nursing

中图分类号: 

  • R473.6
[1] Oh SW, Han SY.Loop diuretics in clinical practice[J].Electrolyte Blood Press,2015,13(1):17-21.DOI:10.5049/EBP.2015.13.1.17.
[2] de Boer NL, Brandt-Kerkhof ARM, Madsen EVE, et al. Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial[J].BMJ Open,2019,9(12):e034508.DOI: 10.1136/bmjopen-2019-034508.
[3] Hu JY, Wang ZX, Wang XR, et al.Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers[J]. Peer J, 2023,11:e15277.DOI: 10.7717/peerj.15277.eCollection 2023.
[4] 周思成, 裴炜, 周海涛, 等. 细胞减灭术联合腹腔热灌注化疗治疗结直肠癌腹膜转移的临床应用与展望[J].中华肿瘤杂志,2022, 44(1):73-78. DOI:10.3760/cma.j.cn112152-20200628-00603.
[5] 刘铎, 王辉, 袁紫旭, 等. 肿瘤细胞减灭术联合腹腔热灌注化疗能否提高结直肠癌腹膜转移患者生存率的Meta分析[J].中华胃肠外科杂志,2021,24(3):256-263. DOI:10.3760/cma.j.cn.441530-20201111-00604.
[6] 杨英, 刘燕, 余雷, 等. 围术期体温管理对腹腔恶性肿瘤行腹腔热灌注化疗患者的影响[J].中华现代护理杂志,2018,24(2):159-161.DOI:10.3760/cma.j.issn.1674-2907.2018.02.008.
[7] 中国抗癌协会肿瘤麻醉与镇痛专业委员会, 中华医学会麻醉学分会肿瘤与麻醉学组.肿瘤细胞减灭术联合腹腔热灌注化疗麻醉暨围术期管理专家共识(2022版)[J].中华麻醉学杂志,2022,42(7):794-806.DOI:10.3760/cma.j.cn131073.20220427.00703.
[8] 中国抗癌协会腹膜肿瘤专业委员会, 广东省抗癌协会肿瘤热疗专业委员会.中国腹腔热灌注化疗技术临床应用专家共识(2019版)[J].中华医学杂志,2020,100(2):89-96. DOI:10.3760/cma.j.issn.0376-2491.2020.02.003.
[9] Guerra-Londono CE, Owusu-Agyemang P, Corrales G, et al.Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)[J].Ann Surg Oncol,2022,29(3):2089-2099. DOI:10.1245/s10434-021-10929-8.
[10] 陈鑫, 傅双, 庄珊珊, 等.手术患者术中测温方式的最佳证据总结[J].护理学报,2022,29(2):40-44. DOI:10.16460/j.issn1008-9969.2022.02.040.
[11] 王岩, 王哲芸, 叶家欣, 等.降温毯不同预设温度对心脏外科术后患者降温效果及并发症的影响[J]. 护理学报,2021,28(21):67-70. DOI:10.16460/j.issn1008-9969.2021.21.067.
[12] Hendrix RJ, Kassira JP, Lambert LA.Elevated maximum core body temperature during hyperthermic intraperitoneal chemoperfusion (HIPEC) is associated with increased postoperative complications[J]. Ann Surg Oncol, 2020,27(1):232-239.DOI:10.1245/s10434-019-07495-5.Epub 2019 Jul 8.
[13] Kumar A, Suman S, Pandey JK, et al.Does hyperthermic intraperitoneal chemotherapy (HIPEC) decrease the threshold of arrhythmia intraoperatively?[J]. Asian J Anesthesiol,2019, 57(1):21-22.DOI: 10.6859/aja.201903_57(1).0005.
[14] Rubio-López JD, Durán-Martínez M, Moreno-Blázquez A, et al.Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy[J]. Langenbecks Arch Surg,2023,408(1):34.DOI: 10.1007/s00423-023-02770-2.
[15] Hübner M, Kusamura S, Villeneuve L,et al.Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy(HIPEC): Enhanced recovery after surgery (ERAS ) society recommendations-part I: Preoperative and intraoperative management[J].Eur J Surg Oncol,2020,46(12):2311-2323.DOI:10.1016/j.ejso.2020.07.041.
[16] 熊中雨, 易凤琼, 曾彦超, 等. 长纤聚酯纤维铺巾在神经外科手术中的应用观察[J].中国实用护理杂志,2020,36(30):2358-2361.DOI:10.3760/cma.j.cn211501-20191226-03821.
[17] 连欢. 护士长纤聚酯纤维手术铺单使用风险体验的质性研究[J].天津护理,2023,31(6):660-665.DOI:10.3969/j.issn.1006-9143.2023.06.007.
[18] 徐文苏, 冯建萍, 张倩. 联合复温护理在婴幼儿深低温体外循环手术中的应用[J].江苏医药,2016, 42(12):1421-1422.DOI:10.19460/j.cnki.0253-3685.2016.12.039.
[19] 葛经武, 杜祥飞, 乔玫. 充气式保温毯上半身加温对侧卧位胸腔镜手术患者术中低体温的干预效果[J].中国实用护理杂志, 2021, 37(10):733-738.DOI:10.3760/cma.j.cn211501-20200320-01305.
[20] Ramirez MF, Guerra-Londono JJ, Owusu-Agyemang P,et al.Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy[J]. Front Oncol,2023,12:1062158.DOI: 10.3389/fonc.2022.1062158.
[1] 陈思齐, 刘宁, 侯晓敏, 卢舒颖. 机器人胃癌手术围术期加速康复外科护理的最佳证据总结[J]. 护理学报, 2024, 31(8): 31-36.
[2] 于凤霞, 于媛. 食管癌围手术期加速康复外科护理专家共识[J]. 护理学报, 2024, 31(17): 61-65.
[3] 周毅峰, 杨继平, 彭瑶丽, 袁浩, 石泽亚. 体外循环心脏手术中体温管理循证实践[J]. 护理学报, 2022, 29(3): 40-45.
[4] 周毅峰, 杨继平, 袁浩, 吴娟. 体外循环心脏手术中体温管理证据汇总[J]. 护理学报, 2021, 28(5): 26-31.
[5] 陈桂丽, 钟美浓, 黄师菊, 林华芬, 黄慧虹. 1例肾癌合并肝后高位下腔静脉癌栓患者的护理[J]. 护理学报, 2020, 27(1): 62-63.
[6] 柏艳芳,黄中英,李凤姣,周怡. 腹腔热灌注化疗在卵巢癌患者细胞减灭术中的应用配合[J]. 护理学报, 2014, (8): 64-65.
Viewed
Full text


Abstract

Cited
  Shared   
No Suggested Reading articles found!